CPI-455
CAS: 1628208-23-0
Ref. 3D-DQC20823
| 1g | 764.00 € | ||
| 2g | 1,160.00 € | ||
| 100mg | 310.00 € | ||
| 250mg | 453.00 € | ||
| 500mg | 647.00 € |
Product Information
CPI-455 is a small molecule that inhibits the lysine methyltransferase (KMT) family of enzymes. It has been shown to inhibit the proliferation of prostate cancer cells and induce apoptosis in vitro. CPI-455 also prevents transcriptional regulation by inhibiting the ubiquitination of histone H3 on lysine 9, which is an important epigenetic modification for gene expression. This drug also has synergistic effects with other agents, including dextran sulfate, which are used to treat cancer. The chemical biology of CPI-455 is being investigated in order to better understand its mechanism of action and potential therapeutic uses.
Chemical properties
Technical inquiry about: 3D-DQC20823 CPI-455
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
